Biotechnology
Healthcare
Market News
Technology
The Market Buzz
BioLineRx Announces Positive Results from GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Multiple Myeloma Patients
BioLineRx Ltd. (NASDAQ: BLRX) shares jumped more than 48% after the biopharmaceutical company announced positive results from a planned interim analysis of the ongoing GENESIS Phase 3 trial of motixafortide...